Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luc Manlay"'
Autor:
Anthony Buisson, Lysa Blanco, Luc Manlay, Maud Reymond, Michel Dapoigny, Olivier Rouquette, Anne Dubois, Bruno Pereira
Publikováno v:
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases, 2022, ⟨10.1093/ibd/izac065⟩
Inflammatory Bowel Diseases, 2022, ⟨10.1093/ibd/izac065⟩
Background The best management after ileocolonic resection is still unknown in Crohn’s disease (CD). We compared step-up and top-down approaches to prevent short and long-term postoperative recurrences in CD patients. Methods From a comprehensive d
Autor:
Anthony Buisson, Maria Nachury, Maud Reymond, Clara Yzet, Pauline Wils, Laure Payen, Marie Laugie, Luc Manlay, Nicolas Mathieu, Bruno Pereira, Mathurin Fumery
Publikováno v:
Clinical Gastroenterology and Hepatology.
We assessed the effectiveness of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel diseases (IBDs) treated with or without intensified intravenous regimen.In this multicenter observational study, IBD patients i
Autor:
Anthony Buisson, Lysa Blanco, Luc Manlay, Maud Reymond, Michel Dapoigny, Olivier Rouquette, Anne Dubois, Bruno Pereira
Publikováno v:
Gastroenterology. 162:S-604
Autor:
Anthony Buisson, Maria Nachury, Maud Reymond, Clara Yzet, Pauline Wils, Laure Payen, Luc Manlay, Bruno Pereira, Mathurin Fumery
Publikováno v:
Gastroenterology. 162:S-182
Autor:
Luc Manlay, Gilles Boschetti, Bruno Pereira, Bernard Flourié, Michel Dapoigny, Maud Reymond, Elisa Sollelis, Claire Gay, Mathilde Boube, Anthony Buisson, Stéphane Nancey
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (12), pp.1289-1299. ⟨10.1111/apt.16377⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2021, 53 (12), pp.1289-1299. ⟨10.1111/apt.16377⟩
International audience; Background The best option between vedolizumab and ustekinumab after anti-tumour necrosis factor (TNF) failure remains unclear in Crohn's disease.Aims To compare the short- and long-term effectiveness of vedolizumab and usteki
Publikováno v:
Gastroenterology. 160:S-6